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Abstract Flavonoids, natural plant constituents, protect against
peroxynitrite and can thereby play a role in defense against this
mediator of inflammation. Procyanidin oligomers of different
size (monomer through nonamer), isolated from the seeds of
Theobroma cacao, were examined for their ability to protect
against peroxynitrite-dependent oxidation of dihydrorhodamine
123 and nitration of tyrosine. By molarity, oligomers were more
effective than the monomeric epicatechin; the tetramer was
particularly efficient at protecting against oxidation and
nitration reactions. These results suggest that epicatechin
oligomers found in cocoa powder and chocolate may be a potent
dietary source for defense against peroxynitrite.
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1. Introduction
Flavonoids occur in di¡erent classes, including procyani-
dins, as natural products in plants, and these polyphenols
are ingested with the diet [1,2]. Flavonoids are general free
radical scavengers [3] and chelate transition metals [4,5]. Pro-
cyanidins (e.g. epicatechin) are exceptionally e⁄cient radical
scavengers [6,7]. Possible health bene¢ts of polyphenols in-
clude suppression of in£ammatory cytokine production [8,9],
protection against cardiovascular disease [10,11], and anticar-
cinogenic e¡ects [12,13].
Peroxynitrite, a potent oxidizing and nitrating species, leads
to tissue damage in a number of pathological conditions in
humans and in experimental animals [14,15]. The physiolog-
ical and pharmacological strategies for protection against per-
oxynitrite are organized into three categories: prevention, in-
terception, and repair (see [16,17]). Flavonoids react with nitric
oxide [18], superoxide [19,20] and protect against peroxyni-
trite-dependent oxidation [21] and nitration [22], and can
thereby play a direct role in interception of peroxynitrite
and its precursors. Here, the procyanidin, (3)-epicatechin,
and the respective procyanidin oligomers ranging up to the
nonamer, isolated from Theobroma cacao, are examined for
their ability to protect against peroxynitrite-dependent oxida-
tion and nitration reactions.
2. Materials and methods
2.1. Reagents
Procyanidin oligomers were puri¢ed from Cocoapro cocoa [23,24],
kindly supplied by Mars, Inc. (Hackettstown, NJ, USA). The oligo-
meric composition of the respective procyanidin preparations is given
in Table 1. Stock solutions (10 mg/ml) of the tested procyanidin prep-
arations were made in methanol, but were readily soluble in aqueous
solutions used in the studies. The absorbance at 280 nm of 25 Wg/ml
aliquots of these stocks was similar in all preparations (0.460 þ 0.040
absorbance units, mean value þ S.D. (n = 9)). Diethylenetriamine pen-
taacetic acid (DTPA), (3)-epicatechin, and (3)-epigallocatechin gal-
late were from Sigma (Deisenhofen, Germany). Dihydrorhodamine
123 (DHR-123) was from Molecular Probes (Eugene, OR, USA).
MnO2 was from Fluka (Buchs, Switzerland). 2-Phenyl-1,2-benziosele-
nazol-3(2H)-one (ebselen) was kindly provided by Rho“ne-Poulenc-
Rorer (Cologne, Germany). Peroxynitrite was synthesized from so-
dium nitrite and H2O2 using a quenched-£ow reactor [25], and
H2O2 was eliminated by passage of the peroxynitrite solution over
MnO2 powder. The ¢nal peroxynitrite concentration was determined
spectrophotometrically at 302 nm (O= 1700 M31 cm31).
2.2. Assay of peroxynitrite-mediated oxidation of dihydrorhodamine
123
The peroxynitrite-mediated oxidation of dihydrorhodamine 123 was
performed as described by Kooy et al. [26] using minor modi¢cations
[27]. Brie£y, peroxynitrite (100 nM) was added to 0.5 WM dihydro-
rhodamine 123 and di¡erent concentrations of procyanidin oligomers
in 0.1 M phosphate bu¡er, 0.1 mM DTPA, pH 7.3, under intense
stirring at room temperature, and £uorescence was detected with a
£uorescence spectrophotometer LS-5 (Perkin-Elmer, Norwalk, CT,
USA) with excitation and emission wavelengths of 500 nm and
536 nm, respectively. There was no signi¢cant interference of the
test compounds in £uorescence determination of DHR-123. The e¡ect
of vehicle (0.3^1.5% methanol) under these conditions was negligible.
2.3. Assay of peroxynitrite-mediated nitration of tyrosine
Protection against peroxynitrite-mediated nitration of tyrosine was
performed as described by Pannala et al. [22] with minor modi¢ca-
tions. Peroxynitrite (500 WM) was added by bolus addition under
constant vortexing to 100 WM tyrosine in 0.1 M phosphate bu¡er
(pH 7.3) containing 0.1 mM DTPA. Under these conditions, e¡ects
of the tested compounds (0^20 WM) were determined. Samples (50 Wl ;
containing 100 WM 3-hydroxy-4-nitrobenzoic acid as an internal
standard) were injected onto a C-18 reverse-phase column (150U4.6
mm; Merck, Darmstadt, Germany) with a Waters 720 WISP auto-
sampler. Separation was performed with a 50 mM potassium phos-
phate bu¡er (pH 7.0)/acetonitrile step-gradient on a Merck-Hitachi L-
655A 12 HPLC unit coupled with a Merck-Hitachi L-5000 controller
unit, at a £ow rate of 1.0 ml/min. The initial bu¡er/acetonitrile ratio
was 95/5, followed by a stepwise decrease to 50/50 at 5 min; after 13
min, the ratio was returned to 95/5 and maintained for an additional
13 min. Such a step-gradient was necessary to achieve separation of
the compounds of interest and then to elute the £avonoids. The 3-
nitrotyrosine formation was monitored with a Merck-Hitachi L-4200
UV/Vis detector equipped with a D-2500 Chromato-Integrator at 430
nm. Calibration curves of the ratio of peak area of 3-nitrotyrosine
standard vs. internal standard were used to determine concentrations.
2.4. Estimations of molar concentrations of oligomers
Although the oligomeric preparations contained contributions from
other oligomers (see Table 1), the purity of a number of the prepara-
tions was su⁄cient (s 90%) to approximate half-maximal inhibitory
concentrations for the inhibition of dihydrorhodamine 123 oxidation
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and tyrosine nitration by peroxynitrite in terms of molarity. For these
estimations, the purity of the major oligomer in question was used
(e.g. dimer = 99%).
3. Results and discussion
3.1. Protection by procyanidin oligomers against the oxidation
of dihydrorhodamine during bolus addition of peroxynitrite
Fig. 1A illustrates the protective e¡ect of some polyphenols,
and Table 2 summarizes the protection of all tested com-
pounds against peroxynitrite-mediated oxidation of DHR-
123. For comparison, the results obtained with ebselen are
also shown (Table 2). The half-maximal inhibitory concentra-
tion of ebselen was V150 nM, similar to our previous ¢nd-
ings [27,28] ; it should be noted that in a di¡erent assay sys-
tem, another group observed higher values (e.g. 2 WM [21]),
underlining the necessity to consider assay conditions when
comparisons are performed. When concentrations of the var-
ious compounds are compared by weight, epigallocatechin
gallate (Table 2) was the most e¡ective of the catechin poly-
phenols, and epicatechin (Table 2; Fig. 1A, open circles) was
more e¡ective than the oligomers (Table 2, Fig. 1A). How-
ever, when concentrations were expressed in terms of molarity
(Table 2), the procyanidin oligomers were more e¡ective than
epicatechin (224 nM), and a number of the oligomers were
more e¡ective than ebselen (160 nM) and epigallocatechin
gallate (111 nM). The tetrameric compound had a half-max-
imal inhibitory concentration less than 100 nM (Table 2).
3.2. Protection by procyanidin oligomers against nitration of
tyrosine by peroxynitrite
Fig. 1B depicts the protective e¡ect of some polyphenols,
and Table 2 summarizes the protection of all tested com-
pounds against nitration of tyrosine (100 WM) by peroxyni-
trite (500 WM). Nitration of tyrosine in the absence of test
compounds, but in the presence of vehicle (0.3% methanol)
was V30 WM; this value was set at 100%. Epicatechin and
epigallocatechin gallate were relatively e⁄cient inhibitors of
tyrosine nitration by peroxynitrite (12 and 9 WM, respectively;
Table 2). The tetramer again was particularly e⁄cient, inhib-
iting tyrosine nitration more than the trimer or the pentamer
(Fig. 2; Table 2).
For the pentamer and smaller oligomers, an association was
observed between the ability of the tested compounds to in-
hibit DHR-123 oxidation and tyrosine nitration by peroxyni-
trite (Fig. 2); however, while the hexamer, heptamer, octamer,
and nonamer were only moderately e¡ective at preventing the
oxidation of DHR-123, they were relatively e⁄cient at inhib-
iting tyrosine nitration (Table 2; Fig. 2). Since the chemical
mechanisms of oxidation of DHR-123 and of nitration of
tyrosine by peroxynitrite are di¡erent [26,29], compounds do
Fig. 1. Protection by procyanidin oligomers against dihydrorhod-
amine 123 oxidation and tyrosine nitration caused by peroxynitrite.
Oxidation of dihydrorhodamine 123 (panel A) was determined £uo-
rometrically as described in Section 2. Peroxynitrite (100 nM) was
added to 0.5 WM dihydrorhodamine 123 and di¡erent concentra-
tions of procyanidin oligomers in 0.1 M phosphate bu¡er, 0.1 mM
DTPA, pH 7.3, under intense stirring at room temperature. 3-Nitro-
tyrosine formation (panel B) was determined by HPLC with absorb-
ance detection as described in Section 2. Peroxynitrite (500 WM) was
added by bolus addition to 100 WM tyrosine and di¡erent concen-
trations of procyanidin oligomers in 0.1 M phosphate bu¡er (pH
7.3) containing 0.1 mM DTPA. Key: epicatechin (open circles),
dimer (closed squares), tetramer (open triangles), pentamer (closed
upside-down triangles), hexamer (open diamonds), octamer (closed
hexagons). Results are means þ S.D. (n = 3^6). See Table 2 for sum-
mary data.
Table 1
Procyanidin oligomer preparations isolated from cocoa (in percent)
Oligomeric preparation
Dimer Trimer Tetramer Pentamer Hexamer Heptamer Octamer Nonamer
Monomer 1.0
Dimer 99.0 5.2 0.5 0.3 0.2 0.4 0.3 0.3
Trimer 94.8 4.1 0.6 0.4 0.4 0.3 0.3
Tetramer 95.4 5.8 2.9 1.5 0.8 0.9
Pentamer 92.0 7.2 4.9 1.4 1.4
Hexamer 1.3 86.2 25.1 9.1 5.5
Heptamer 1.3 61.0 12.9 4.1
Octamer 0.8 2.8 64.6 10.8
Nonamer 1.0 3.9 10.6 76.7
The bold numbers designate the major oligomer of the fraction. Top row indicates preparation used, oligomer composition is shown on the
vertical axis. Data are as provided by supplier; see also [23,24].
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not necessarily have to be equally e¡ective in both assays.
Previous studies have shown that polyphenolic compounds
may be both oxidized and nitrated by peroxynitrite [30,31].
The observed di¡erences could therefore result from the hexa-
mer and larger oligomers not being as e⁄cient protecting
against oxidation by peroxynitrite, but more e⁄cient targets
for nitration reactions. Indeed, as described previously, many
of the compounds tested here exhibited an increase in absorb-
ance at 430 nm upon reaction with peroxynitrite (data not
shown), suggesting nitration of the polyphenols [22].
3.3. Implications
The role of dietary polyphenols in health and disease has
received recent attention (see [32,33]). These compounds have
been shown to inhibit oxidation [21] and nitration reactions
[22] as well as DNA damage and strand breakage [34,35]
caused by peroxynitrite. The presence of procyanidin oligo-
mers in chocolate products has been previously described
[23,36]. These compounds were shown here to be highly e¡ec-
tive at preventing oxidation and nitration reactions caused by
peroxynitrite, some more e¡ective than monomeric (3)-epica-
techin on a molar basis. Recent studies have also demon-
strated di¡erential e¡ects of procyanidin oligomers compared
to the monomeric compounds. For example, procyanidin
oligomers (dimer and trimer) isolated from apple juice were
found to exhibit higher growth-promoting activity for hair
epithelial cells than the monomeric (3)-epicatechin [37]. Re-
sults of a Dutch nutritional study suggested that while tea
contributed 55% of dietary catechin intake, chocolate contrib-
uted 20% [38], indicating that catechins from chocolate may
be a signi¢cant source of antioxidant defense against peroxy-
nitrite ; however, this study did not take into account the
more abundant oligomers found in chocolate, present in
only minor concentrations in tea. Further, since cocoa gener-
ates less hydrogen peroxide than tea [39], cocoa may be a
preferable source of antioxidant polyphenols. While epicate-
chin from chocolate was found to reach a concentration of 0.7
WM in plasma after intake of 80 g black chocolate [40], it is
not yet known how well cocoa procyanidin oligomers are
absorbed into the bloodstream. Recent work by Spencer et
al. [41] using the isolated rat intestine showed that for certain
£avonoids, glucuronidation and possibly other metabolism
may occur at the level of the intestinal mucosa. The physico-
chemical basis for the special properties described here for the
tetrameric compound will be a challenging topic of research.
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Fig. 2. Comparison of the half-maximal inhibitory concentrations of
epicatechin and procyanidin oligomers. Data are as summarized in
Table 2 and represented in Fig. 1. The half-maximal inhibitory con-
centrations for dihydrorhodamine 123 formation (ng/ml; closed
circles) and 3-nitrotyrosine formation (Wg/ml; closed squares) plotted
vs. oligomer length (e.g. ‘2’ = dimer).
Table 2
Half-maximal inhibitory concentrations of epicatechins, procyanidin oligomers, and ebselen in peroxynitrite-mediated oxidation of dihydrorhod-
amine 123 and nitration of tyrosine
Compound MW (Da) DHR-123 oxidation Tyrosine nitration
(half-maximal inhibitory concentration)
ng/ml nM Wg/ml WM
Epigallocatechin gallate 458 51 111 4.1 9.0
Epicatechin 290 65 224 3.5 12.0
Dimer 578 95 162a 7.0 12.0a
Trimer 866 125 137a 9.0 9.8a
Tetramer 1154 100 83a 5.2 4.3a
Pentamer 1442 235 150a 23.3 14.8a
Hexamer 1730 210 ^ 3.5 ^
Heptamer 2018 285 ^ 6.5 ^
Octamer 2306 190 ^ 8.3 ^
Nonamer 2594 180 ^ 5.4 ^
Ebselen 274 45 160 n.d. ^
The oxidation of dihydrorhodamine 123 and nitration of tyrosine by peroxynitrite was determined as described in Section 2. See also Figs. 1
and 2.
n.d., not determined.
aCalculated using oligomer composition data (see Table 1 and Section 2). Contributions of other procyanidin oligomers to the hexamer, hep-
tamer, octamer and nonamer preparations were s 10%, so calculation of molarity was inappropriate for these.
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